Aspiring investors and financial enthusiasts alike are always keen to gain insights into the strategies of the world’s most successful investors. With their vast wealth and unparalleled experience, billionaire investors are often viewed as beacons of wisdom in the stock market. Today we’ll take a closer look at three stocks that have caught the attention of billionaire investors, offering a glimpse into their investment portfolios and potential opportunities for investors looking to follow in their footsteps.
Here are three stocks investment legends have been buying recently –
ADMA Biologics, Inc. – SYM: ADMA
Recent Price: $3.22
Legends: Steven Cohen, Joel Greenblatt, Jim Simons
Description: ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
Algonquin Power & Utilities Corp. – SYM: AQN
Recent Price: $8.79
Legends: Joel Greenblatt, Steven Cohen, Jim Simons
Description: Algonquin Power & Utilities Corp., a renewable energy and utility company, that provides energy and water solutions and services in North America and internationally. The company operates through two segments, Regulated Services Group and Renewable Energy Group. The Regulated Services Group segment provides a portfolio of rate-regulated water, electricity, and gas utility services. It offers electricity distribution, water distribution, waste water treatment, and natural gas distribution services. The Renewable Energy Group segment generates and sells electrical energy produced by its portfolio of renewable power generation facilities primarily in the United States and Canada. It owns and operates hydroelectric, wind, solar, renewable natural gas, and thermal facilities. Algonquin Power & Utilities Corp. was incorporated in 1988 and is headquartered in Oakville, Canada.
Smith & Nephew plc – SYM: SNN
Recent Price: $29.73
Legends: Steven Cohen, Jim Simons, Ray Dalio
Description: Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.